source
- Opinion: It’s time to seize the rare bipartisan opening to address microplastics“This could be the start of serious action on microplastics. Or it could end up as a headline with little behind it,” write Tim Ryan and Justin Zorn.STAT · 3mo ago↗ source
- Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs“We're basically not using our body as directed,” says "Drug Story" host Thomas Goetz.STAT · 3mo ago↗ source
- Fierce Biotech Fundraising Tracker '26: InduPro assembles $77M; Vaderis nets $152M series BThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.Fierce Biotech · 7mo ago↗ source